Sunovion speaks about the clinical trial re-opening criteria and strategies to navigate unexpected challenges and the impact of COVID-19. Signant Health’s Dan Debonis details how rater training and digital solutions, like telemedicine, can enable remote clinical trials without sacrificing data integrity. Dan also differentiates the three approaches for remote visits: specified, optional, and contingency.

Signant’s Alan Kott discusses how data analytics can be used to track the impact of COVID-19 on clinical trials. Dr. Bill Byrom, Signant’s VP of Product Strategy and Innovation, talks about mixing data collection modes, addresses industry concerns for mixing modes, and